National · 1 sources
Marksans Pharma Q2 Profit Soars 45% To ₹143.5 Crore, Revenue Crosses ₹900 Crore For First Time As Global Business Shines
Coverage by lean
0% Left100% Centre0% Right
Left 0
No coverage found on this side
Centre 1
Right 0
No coverage found on this side
One headline per side, the first Trikon holds. Every outlet is listed below.
Left · 0
No coverage found on this side.
Centre · 1
Free Press Journal · Centre
Marksans Pharma Q2 Profit Soars 45% To ₹143.5 Crore, Revenue Crosses ₹900 Crore For First Time As Global Business Shines
◈ Indian National Press (Bombay), Karnani family
Right · 0
No coverage found on this side.
Verify with IFCN fact-checkers →FactlyIFCN ↗Quint WebQoofIFCN ↗Vishvas NewsIFCN ↗NewsCheckerIFCN ↗Google Fact Check ↗